简介:摘要:目的:在创伤急救中心构建院前院内协同救治的5G+医疗信息平台,分析其应用效果。方法:选择2022年1月-2022年12月创伤急救中心接诊的180例创伤外科患者按简单数字随机分组法分为对照组与观察组各90例,对照组采用常规救治方法,观察组则基于5G、物联网、紫云信息系统以及虚拟现实VR技术支持构建院前院内协同救治的5G+医疗信息平台进行救治,比较不同救治模式下2组患者的救治效果。结果:观察组的专科医师会诊时间、快速CT扫描时间以及抢救室治疗时间均显著低于对照组,数据有统计学意义,P<0.05。结论:在创伤急救中心建设院前院内协同救治5G+医疗信息平台具有良好的应用效果,可显著缩短创伤外科患者的急救时间,提高抢救成功率。
简介:摘要:医院感染,在临床上也被称之为医源性感染,为了有效防控医院感染,需采取隔离、灭菌、消毒等基本措施,在护理部、护士长及医院感染管理办公室专职人员指导下,监督、检查本科室医院感染管理制度、消毒隔离制度、无菌操作常规的落实情况。
简介:摘要:医院感染,在临床上也被称之为医源性感染,为了有效防控医院感染,需采取隔离、灭菌、消毒等基本措施,在护理部、护士长及医院感染管理办公室专职人员指导下,监督、检查本科室医院感染管理制度、消毒隔离制度、无菌操作常规的落实情况。
简介:·AIM:Toevaluateandcomparetheefficacyandstabilityofintrastromalcornealringsegment(ICRs)implantationwithcross-linking(CXL)usingdifferentsequenceandtiming.·METHODS:Inthissingleretrospectivestudy,86keratoconiceyessubjectedtheICRsimplantation.Weanalyzedonly41eyesthathadcompletefollow-ups.Theyweredividedintothreegroups:ICRsimplantationwasappliedonly(groupnormal),ICRsfirstfollowedbyCXLimmediately(groupCXL-S),CXLfirstfollowedbyICRslongafter(groupCXL-B).Thevisualacuity,refractiveresults,keratometrywerecomparedpreoperativelyand1ypostoperatively.Theirdifferencesamongthethreegroupswerealsoanalyzed.·RESULTS:Groupnormalcomprised25eyes,groupCXL-S8eyes,andgroupCXL-B8eyes.Therewereimprovementsinthemeanuncorrecteddistancevisualacuity(UDVA)andthemeancorrecteddistancevisualacuity(CDVA)comparedpreoperativelyand1ypostoperatively[UDVA:0.31(P=0.030)logarithmicminimumangleofresolution(logMAR)groupnormal,0.4(P=0.020)groupCXL-S,0.45(P=0.001)groupCXL-B;CDVA:0.21logMAR(P=0.013)groupnormal,0.30(P=0.036)groupCXL-S;0.26(P=0.000)groupCXL-B].Therefractiveandtopographicoutcomesalsoshowedimprovements.Intermsofcomparisonsamongthethreegroups,allthePvalueswereabove0.05,showingnosignificantdifference.ButonlygroupCXL-BhadimprovementinUDVAandCDVAforallthepatients.·CONCLUSION:Withsafetyandgoodvisualoutcomes,ICRsimplantationisaviablealternativeforkeratoconus.Nosignificantdifferencewasfoundamongthesethreegroups.
简介:ObjectivesToevaluateantihypertensiveefficiencyandsafetyofanewdomesticofL-&N-typeCa^2+antagonist-eilnidipinewithimidaprilasapositivecontrol.MethodsAfter2weeks'placebowashingout,22patientsweretreatedwitheilnidipine5mgdailyand27patientsweretreatedwithimidapril5mgdaily.4weekslater,ifpatient'ssittingdiastolicbloodpressureisover90mmHg,his/herdosagewasdoubledforanother4weeks,theothersmeasuringupremainedtheirdosageunchangedforanother4weeks.Bloodpressure,heartrate,bloodandurineroutineexamination,serumglucose,serumchemicalexaminationincludingtotalcholesterol,triglyceride,HDL,LDL,transaminase,creatineetcandsidereactionswererecordedbeforeandafterthetrial.Datawereanalyzedstatistically.ResultsAfter8weeks'treatment,bloodpressurewassignificantlydecreased(P<0.05)inbothgroups,andthetwomedicineshadsimilarantihypertensiveeffects.Furthermore,thereducingofheartratewasstatisticallysignificantcomparedwithbaseline(P<0.01)inthecilnidipinegroup,butnotintheimidaprilgroup.Thenegativechronotropiceffectofcilnidipinehadlittleeffectoncontinuingthetherapy.Therewerenochangesonbloodandurineroutineexaminationandserumlipid,serumglucose,creatine,transaminaseandetcinbothgroups.Theirsidereactionsweremildandwell-tolerated.ConclusionsCilnidipinehasacon-vincingantihypertensiveeffectsimilartothatofimi-dapril.Especiallycilnidipinemaybeadministeredtopatientswithrelativelymildtachycardia.
简介:摘要:麻醉是医学发展过程中的一个重要成绩,其出现使得外科手术得以大范围应用,并且治疗安全水平也得到大幅度提升。作为一个复杂的学科,患者以及家属自然无法洞悉其本质,但是对麻醉做一些千层面的了解仍然十分必要。本文从发展的角度对麻醉展开了分析,并且进一步对麻醉工作的分类和适用环境加以讨论,对于加强该领域的认知有着积极意义。
简介:摘要目的探讨院前急救创伤评分方法在院前急救患者中应用的效果。方法将我院进行院前急救的患者随机分为对照组和观察组各210例,对对照组患者采用传统的院前急救常规监护方法,对观察组患者采用RTS创伤评分方法评估患者的病情,对比分析两组患者的现场明确急救诊断及现场抢救、转运、急诊科抢救、病房内结果。结果观察组的明确急救诊断率为986%显著高于对照组40%,观察组的现场急救成功率为985%高于对照组的942%,观察组的转运成功率为100%显著高于对照组的942%,观察组的急诊科抢救成功率为986%高于对照组的964%,观察组在病房2h内的存活率为99%高于对照组的968%。两组比较均为p<005,差异有统计学意义。
简介:TheZ10andZ37strainsofhemorrhagicfeverwithrenalsyndrome(HFRS)virusandtheMongoliangerbil(Merionsunguiculatus)kidneycellswereusedtopreparetheinactivatedbivalentvaccine.AphaseⅡclinicaltrialuseofthisvaccinewasmadein750Chinesevolunteers.Theresultsshowedthatthesidereactionratewas2.5%andthesero-conversionrateofneutralizingantibodiesagainstHantaanandSeoulvirusesintheinoculatedvolunteerswere87.6%and96.3%respectively.